Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04603014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients

Study acronym: IPUF-HD
StatusActive, Not Recruiting
PhasePhase 2
Started2021-01-01
View on ClinicalTrials.gov ↗

Amendment history

2026-04-28
minor
Study Status, Oversight v8
Primary completion date2025-12-30→2026-12-30
Completion date2025-12-30→2026-12-30
2025-09-25
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v7
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2025-06-30→2025-12-30
Completion date2025-11-30→2025-12-30
Study sitesdetails revised at 1 of 1 site
2025-02-10
minor
Study Status, Oversight v6
Primary completion date2024-11-30→2025-06-30
Completion date2024-12-31→2025-11-30
2024-08-13
minor
Study Status v5
Primary completion date2024-06-30→2024-11-30
2024-02-08
minor
Study Status v4
Primary completion date2023-12-30→2024-06-30
Completion date2023-12-31→2024-12-31
Show 3 earlier versions
2023-08-30
minor
Study Status v3
Primary completion date2023-06-30→2023-12-30
Completion date2023-07-31→2023-12-31
2022-12-20
minor
Study Status v2
Primary completion date2021-12-31→2023-06-30
Completion date2022-04-30→2023-07-31
2021-01-22
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2020-10-21
minor
Original filing
Sodium accumulates in the tissues of patients with kidney disease and impairs survival. Three-times weekly, standard hemodialysis alone cannot remove excess sodium efficiently. A sample of 10 chronic hemodialysis patients will undergo a 5-week, pilot, interventional study to test the efficacy of additional sodium removal in-between hemodialysis sessions, twice per week, for three weeks. Tissue sodium removal will be achieved with peritoneal dialysis after the surgical insertion of a peritoneal dialysis catheter. Tissue sodium removal will be assessed at the beginning and at the end of the study with sodium magnetic resonance imaging of a peripheral limb (leg). Patients will also undergo monitoring for symptoms and blood pressure throughout the study to assess the safety of this procedure.
Trial Details
NCT Number NCT04603014
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Sequana Medical N.V.
Conditions End Stage Renal Disease on Dialysis, Hemodialysis, Peritoneal Dialysis, Nonosmotic Sodium Storage
Enrollment 10 participants
Start Date 2021-01-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-04